S

Stereotaxis Inc
F:RJR1

Watchlist Manager
Stereotaxis Inc
F:RJR1
Watchlist
Price: 0.671 EUR 9.64% Market Closed
Market Cap: €15.3m

Relative Value

RJR1 price has not been updated for more than 6 years. This may indicate that the stock has been delisted.
RJR1 doesn't have a meaningful market cap.

The Relative Value of one RJR1 stock under the Base Case scenario is hidden EUR. Compared to the current market price of 0.671 EUR, Stereotaxis Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RJR1 Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

RJR1 Competitors Multiples
Stereotaxis Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Stereotaxis Inc
F:RJR1
200.4m EUR 6.3 -8.1 -8.4 -7.9
US
Abbott Laboratories
NYSE:ABT
190.1B USD 4.3 29.1 16.5 22.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.4B USD 18 63.4 48.5 58.6
US
Stryker Corp
NYSE:SYK
140.5B USD 5.8 47.9 23.3 28.2
US
Boston Scientific Corp
NYSE:BSX
139.4B USD 7.2 49.9 29.2 39.8
IE
Medtronic PLC
NYSE:MDT
131.6B USD 3.8 27.6 15.5 22.4
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD 2.7 34.7 12.7 21.7
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR 2 22 12.6 17.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.1B USD 13 52.6 37.8 41.8
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD 8.1 34.7 24.7 27.1
US
Resmed Inc
NYSE:RMD
37.1B USD 7.1 25.9 18.6 20.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
S
Stereotaxis Inc
F:RJR1
Average EV/EBITDA: 23.9
Negative Multiple: -8.4
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
48.5
24%
2
US
Stryker Corp
NYSE:SYK
23.3
13%
1.8
US
Boston Scientific Corp
NYSE:BSX
29.2
22%
1.3
IE
Medtronic PLC
NYSE:MDT
15.5
8%
1.9
US
Becton Dickinson and Co
NYSE:BDX
12.7
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.6
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.8
14%
2.7
US
Edwards Lifesciences Corp
NYSE:EW
24.7
13%
1.9
US
Resmed Inc
NYSE:RMD
18.6
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
S
Stereotaxis Inc
F:RJR1
Average EV/EBIT: 30
Negative Multiple: -7.9
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.5
17%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
58.6
25%
2.3
US
Stryker Corp
NYSE:SYK
28.2
16%
1.8
US
Boston Scientific Corp
NYSE:BSX
39.8
32%
1.2
IE
Medtronic PLC
NYSE:MDT
22.4
17%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.7
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
17.7
15%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.8
15%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
27.1
14%
1.9
US
Resmed Inc
NYSE:RMD
20.6
12%
1.7